Who
Alan Edmund Walts
Director
Company insider
Files Form 4 as: Director, Eloxx Pharmaceuticals.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Apr 2021
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,590 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,590 at $0.00 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,875 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,875 at $0.00 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,875 at $0.00 | filing |
| 24 Jan 2026filed 8 May 2026 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,875 | filing |
| 19 Sep 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —395,680 at $0.00 | filing |
| 19 Sep 2025filed 8 May 2026 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —395,680 at $0.00 | filing |
| 24 Jan 2025filed 28 Jan 2025 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 24 Jan 2025filed 28 Jan 2025 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 16 Oct 2024filed 17 Oct 2024 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 30 Jan 2023filed 31 Jan 2023 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,859 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Dec 2021filed 3 Dec 2021 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —37,695 at $0.00 | filing |
| 1 Dec 2021filed 3 Dec 2021 | ELOX Eloxx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —37,695 at $0.00 | filing |
| 19 May 2021filed 20 May 2021 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,334 at $0.00 | filing |
| 1 Apr 2021filed 2 Apr 2021 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,695 at $0.00 | filing |
| 1 Apr 2021filed 2 Apr 2021 | ELOX Eloxx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.